Abstract:Prion diseases are fatal neurodegenerative disorders that affect humans and animals, and can also be transmitted from animals to humans. A fundamental event in prion disease pathogenesis is the conversion of normal host prion protein (PrPC) to a disease-associated misfolded form (PrPSc). Whether or not an animal prion disease can infect humans cannot be determined a priori. There is a consensus that classical bovine spongiform encephalopathy (C-type BSE) in cattle transmits to humans, and that classical sheep scrapie is of little or no risk to human health. However, the zoonotic potential of more recently identified animal prion diseases, such as atypical scrapie, H-type and L-type BSE and chronic wasting disease (CWD) in cervids, remains an open question. Important components of the zoonotic barrier are (i) physiological differences between humans and the animal in question, (ii) amino acid sequence differences of the animal and human PrPC, and (iii) the animal prion strain, enciphered in the conformation of PrPSc. Historically, the direct inoculation of experimental animals has provided essential information on the transmissibility and compatibility of prion strains. More recently, cell-free molecular conversion assays have been used to examine the molecular compatibility on prion replication and zoonotic potential. One such assay is Protein Misfolding Cyclic Amplification (PMCA), in which a small amount of infected tissue homogenate, containing PrPSc, is added as a seed to an excess of normal tissue homogenate containing PrPC, and prion conversion is accelerated by cycles of incubation and ultrasonication. PMCA has been used to measure the molecular feasibility of prion transmission in a range of scenarios using genotypically homologous and heterologous combinations of PrPSc seed and PrPC substrate. Furthermore, this method can be used to speculate on the molecular profile of PrPSc that might arise from a zoonotic transmission. We discuss the experimental approaches that have been used to model both the intra- and inter-species molecular compatibility of prions, and the factors affecting PrPc to PrPSc conversion and zoonotic potential. We conclude that cell-free prion protein conversion assays, especially PMCA, are useful, rapid and low-cost approaches for elucidating the mechanisms of prion propagation and assessing the risk of animal prions to humans.

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions

The Propagation Of Hamster-Adapted Scrapie Prpsc Can Be Enhanced By Reduced Pyridine Nucleotide In Vitro

Expression of PrP(C) As HIS-fusion Form in a Baculovirus System and Conversion of Expressed PrP-sen to PrP-res in a Cell-Free System.

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of transmissible and rapidly progressive neurodegenerative diseases including Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapi

Remarkable Reduction of MAP2 in the Brains of Scrapie-Infected Rodents and Human Prion Disease Possibly Correlated with the Increase of Calpain

Abnormal Activation of Microglia Accompanied with Disrupted CX3CR1/CX3CL1 Pathway in the Brains of the Hamsters Infected with Scrapie Agent 263K.

Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification

Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique

Re-Infection of the Prion from the Scrapie-Infected Cell Line Smb-S15 in Three Strains of Mice, Cd1, C57bl/6 and Balb/C

Protein Misfolding Cyclic Amplification and Its Application

Successive Passaging of the Scrapie Strains, Me7-Ha and 139A-Ha, Generated by the Interspecies Transmission of Mouse-Adapted Strains into Hamsters Markedly Shortens the Incubation Times, but Maintains Their Molecular and Pathological Properties

Mouse-adapted Scrapie Strains 139A and ME7 Overcome Species Barrier to Induce Experimental Scrapie in Hamsters and Changed Their Pathogenic Features

Dynamic Analyses of PrP and PrP(Sc) in Brain Tissues of Golden Hamsters Infected with Scrapie Strain 263K Revealed Various PrP Forms.

Establishment of A Stable Prpsc Panel from Brain Tissues of Experimental Hamsters with Scrapie Strain 263K

Development of a methodology for large-scale production of prions for biological and structural studies

[Establishment of a Prion Disease PrP(Sc) Panel from the Brain Tissues of Experimental Hamsters Infected with Scrapie Agent 263K].

Heterogeneity of PrP in Brains of Hamsters Infected with Scrapie 263K Strain and the Dynamic Detection by Western Blot

Comparison Study on Clinical and Neuropathological Characteristics of Hamsters Inoculated with Scrapie Strain 263K in Different Challenging Pathways

[Alternations of Tau Protein and Its Phosphorylated Profiles in the Experimental Hamsters Infected by Scrapie Agents 263K and 139A].

Changes of Tau Profiles in Brains of the Hamsters Infected with Scrapie Strains 263 K or 139 A Possibly Associated with the Alteration of Phosphate Kinases